Logo image of LMN.CA

LUMINE GROUP INC (LMN.CA) Stock Fundamental Analysis

TSX-V:LMN - TSX Venture Exchange - CA55027C1068 - Common Stock - Currency: CAD

38.43  -0.3 (-0.77%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to LMN. LMN was compared to 66 industry peers in the Software industry. LMN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. LMN is not overvalued while it is showing excellent growth. This is an interesting combination.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year LMN has reported negative net income.
In the past year LMN had a positive cash flow from operations.
LMN.CA Yearly Net Income VS EBIT VS OCF VS FCFLMN.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 -500M -1B -1.5B -2B -2.5B

1.2 Ratios

LMN has a Return On Assets of -140.38%. This is amonst the worse of the industry: LMN underperforms 83.33% of its industry peers.
The Return On Equity of LMN (-272.04%) is worse than 71.21% of its industry peers.
LMN has a Return On Invested Capital of 5.64%. This is in the better half of the industry: LMN outperforms 74.24% of its industry peers.
Industry RankSector Rank
ROA -140.38%
ROE -272.04%
ROIC 5.64%
ROA(3y)-76.97%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LMN.CA Yearly ROA, ROE, ROICLMN.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 -100 -200

1.3 Margins

The Operating Margin of LMN (12.63%) is better than 80.30% of its industry peers.
LMN's Operating Margin has declined in the last couple of years.
The Profit Margin and Gross Margin are not available for LMN so they could not be analyzed.
Industry RankSector Rank
OM 12.63%
PM (TTM) N/A
GM N/A
OM growth 3Y-9.44%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LMN.CA Yearly Profit, Operating, Gross MarginsLMN.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 -100 -200 -300 -400 -500

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so LMN is destroying value.
The number of shares outstanding for LMN has been increased compared to 1 year ago.
LMN has a worse debt/assets ratio than last year.
LMN.CA Yearly Shares OutstandingLMN.CA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 20M 40M 60M
LMN.CA Yearly Total Debt VS Total AssetsLMN.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

LMN has an Altman-Z score of 7.55. This indicates that LMN is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 7.55, LMN belongs to the best of the industry, outperforming 86.36% of the companies in the same industry.
The Debt to FCF ratio of LMN is 3.37, which is a good value as it means it would take LMN, 3.37 years of fcf income to pay off all of its debts.
LMN's Debt to FCF ratio of 3.37 is fine compared to the rest of the industry. LMN outperforms 66.67% of its industry peers.
A Debt/Equity ratio of 0.44 indicates that LMN is not too dependend on debt financing.
The Debt to Equity ratio of LMN (0.44) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 3.37
Altman-Z 7.55
ROIC/WACC0.44
WACC12.74%
LMN.CA Yearly LT Debt VS Equity VS FCFLMN.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 -1B -2B -3B

2.3 Liquidity

LMN has a Current Ratio of 1.96. This is a normal value and indicates that LMN is financially healthy and should not expect problems in meeting its short term obligations.
LMN has a Current ratio of 1.96. This is in the better half of the industry: LMN outperforms 75.76% of its industry peers.
A Quick Ratio of 1.96 indicates that LMN should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.96, LMN is in the better half of the industry, outperforming 75.76% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.96
Quick Ratio 1.96
LMN.CA Yearly Current Assets VS Current LiabilitesLMN.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 1B 2B 3B 4B

7

3. Growth

3.1 Past

The earnings per share for LMN have decreased strongly by -27.61% in the last year.
LMN shows a strong growth in Revenue. In the last year, the Revenue has grown by 46.96%.
LMN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 44.28% yearly.
EPS 1Y (TTM)-27.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%102.9%
Revenue 1Y (TTM)46.96%
Revenue growth 3Y44.28%
Revenue growth 5YN/A
Sales Q2Q%35.06%

3.2 Future

The Earnings Per Share is expected to grow by 40.49% on average over the next years. This is a very strong growth
Based on estimates for the next years, LMN will show a very strong growth in Revenue. The Revenue will grow by 28.46% on average per year.
EPS Next Y36.84%
EPS Next 2Y40.49%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year31.21%
Revenue Next 2Y28.46%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
LMN.CA Yearly Revenue VS EstimatesLMN.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M
LMN.CA Yearly EPS VS EstimatesLMN.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LMN. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 34.73, which means the current valuation is very expensive for LMN.
Based on the Price/Forward Earnings ratio, LMN is valued cheaply inside the industry as 81.82% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 94.38, LMN is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 34.73
LMN.CA Price Earnings VS Forward Price EarningsLMN.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

LMN's Enterprise Value to EBITDA is on the same level as the industry average.
The rest of the industry has a similar Price/Free Cash Flow ratio as LMN.
Industry RankSector Rank
P/FCF 78.03
EV/EBITDA 36.41
LMN.CA Per share dataLMN.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10 -20 -30

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as LMN's earnings are expected to grow with 40.49% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.49%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

LMN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

LUMINE GROUP INC

TSX-V:LMN (2/11/2025, 7:00:00 PM)

38.43

-0.3 (-0.77%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-01 2024-11-01/amc
Earnings (Next)N/A N/A
Inst Owners12%
Inst Owner ChangeN/A
Ins Owners12.14%
Ins Owner ChangeN/A
Market Cap9.86B
Analysts84
Price Target43.35 (12.8%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-77.1%
Min EPS beat(2)-106.47%
Max EPS beat(2)-47.72%
EPS beat(4)0
Avg EPS beat(4)-4598.29%
Min EPS beat(4)-15283%
Max EPS beat(4)-47.72%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-5.27%
Min Revenue beat(2)-13.33%
Max Revenue beat(2)2.78%
Revenue beat(4)1
Avg Revenue beat(4)-5.89%
Min Revenue beat(4)-13.33%
Max Revenue beat(4)2.78%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)7.59%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)4%
EPS NY rev (3m)4%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 34.73
P/S 11.03
P/FCF 78.03
P/OCF 76.3
P/B 10.44
P/tB N/A
EV/EBITDA 36.41
EPS(TTM)-34.09
EYN/A
EPS(NY)1.11
Fwd EY2.88%
FCF(TTM)0.49
FCFY1.28%
OCF(TTM)0.5
OCFY1.31%
SpS3.49
BVpS3.68
TBVpS-0.93
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -140.38%
ROE -272.04%
ROCE 7.38%
ROIC 5.64%
ROICexc 6.79%
ROICexgc 98.7%
OM 12.63%
PM (TTM) N/A
GM N/A
FCFM 14.13%
ROA(3y)-76.97%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)11.23%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-9.44%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 3.37
Debt/EBITDA 1.51
Cap/Depr 1.76%
Cap/Sales 0.32%
Interest Coverage 4.42
Cash Conversion 46.92%
Profit Quality N/A
Current Ratio 1.96
Quick Ratio 1.96
Altman-Z 7.55
F-Score5
WACC12.74%
ROIC/WACC0.44
Cap/Depr(3y)1.89%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.28%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-27.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%102.9%
EPS Next Y36.84%
EPS Next 2Y40.49%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)46.96%
Revenue growth 3Y44.28%
Revenue growth 5YN/A
Sales Q2Q%35.06%
Revenue Next Year31.21%
Revenue Next 2Y28.46%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y68.74%
EBIT growth 3Y30.66%
EBIT growth 5YN/A
EBIT Next Year198.15%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y103.34%
FCF growth 3Y22.08%
FCF growth 5YN/A
OCF growth 1Y106.31%
OCF growth 3Y22.09%
OCF growth 5YN/A